AI-biotech Terray emerges with $60M

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES AI-biotech Terray emerges with $60M and a solution for data problems in drug R&D Terray Therapeutics uses tiny microarrays to test molecules against targets of interest, then applies artificial intelligence to build large chemical datasets. The startup's Series A financing will support R&D initially in immunology; the first Terray molecule is expected to reach the clinic in 18 months. Medidata talent acquisition director highlights AI job growth   Backed by $100M, Star Therapeutics sets out to find constellations of rare disease By Frank Vinluan Wednesday, February 16, 2022 7:00 AM Star Therapeutics aims to develop drugs for rare diseases, many of which currently have no FDA-approved treatments. The company forms startups focused on particular areas of biology, and its first one, Electra Therapeutics, is going after a rare autoimmune condition that can become fatal in less than four years. Read more » Alexa joins the site staff: how clinical trials tech will evolve in 2022 By J.C. Wilson Tuesday, February 15, 2022 6:56 PM Expect more clinical trial sponsors to embrace these technologies as the industry sees wider adoption of decentralized clinical trials. Read more » Lightfully Behavioral Health acquires 2 of 13 centers it plans to open in California in 2022 By Michael Schroeder Tuesday, February 15, 2022 6:33 PM The Thousand Oaks, California-based company bought Resilience Treatment Center for Mental Health in West Los Angeles for an undisclosed sum and is now accepting patients at two centers it acquired through the purchase. Read more » Can telehealth be here to stay? By Brett Cohen Tuesday, February 15, 2022 6:05 PM Telehealth has proven itself undeniably practical. However, ensuring its long-term survival will require ongoing work and revision, including broadband improvements, permanent Medicare reforms, Interstate Medical Licensure Compact participation and payment parity assurance. Read more » Clinical evidence is a necessity, not a luxury, for digital health companies By Emma Bardin Tuesday, February 15, 2022 4:36 PM Lindsay Sears, VP of evidence generation at One Drop weighs in on the importance of gathering validation for digital health tools and how doing so is essential, not a luxury, moving forward. Read more » AI comes of age during Covid-19: Register now and join us for MedCity INVEST in Chicago By Stephanie Baum Tuesday, February 15, 2022 4:00 PM The conference takes place March 28-30 at the Ritz Carlton hotel in Chicago. Register now and be part of the conversation, take part in networking opportunities and check out startup pitches across pharma tech, medtech, diagnostics, and digital health. Read more » Memora Health brings in $40M to grow its platform, expand partnerships By Michael Schroeder Tuesday, February 15, 2022 9:00 AM Transformation Capital led the funding round with participation from Andreessen Horowitz, Frist Cressey Ventures, Edward Elmhurst Health, AlleyCorp. The new financing enables Memora to meet commercial demand , drive new partnerships and further improve the care delivery experience, said CEO Manav Sevak. Read more » 9 Steps to Become Certified in ISO 13485 From MedCity News Knowing the requirements and how to prepare for the ISO 13485 Certification can be hard. Here are 9 steps to stress free preparation. Download this FREE guide to learn more! MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails